Track topics on Twitter Track topics that are important to you
The principal aim of the study is to evaluate whether attendance at an exercise training and education programme (known as pulmonary rehabilitation) shortly following hospital discharge can lead to a reduction in exacerbations and improvement in exercise capacity and quality of life in patients with chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD), also sometimes known as chronic asthma, bronchitis or emphysema, is an important health problem. Many people with COPD are admitted into hospital with a worsening of their symptoms, known as an exacerbation. Hospitalisations for acute exacerbations of chronic obstructive pulmonary disease (COPD) are a massive burden to the NHS. Over the past decade, these hospitalizations have increased by 50%, and annual hospital costs for COPD in the UK amount to more than £587 million. After being discharged, some people fail to cope very well due to a variety of reasons. A prolonged stay in hospital may lead to muscle weakness, particularly of the leg muscles , a loss of confidence in performing everyday activities, and increased anxiety . A high proportion of these patients are re−admitted to hospital following discharge. The aim of the study is to assess whether attendance at an exercise training and education programme shortly following discharge can firstly, improve exercise capacity and quality of life, and secondly, reduce the use of health resources and costs to the NHS.
It is known that an exercise training and education programme known as Pulmonary Rehabilitation is beneficial to stable patients with COPD by reducing breathlessness, increasing exercise capacity and improving quality of life. We have recently performed a pilot study that has shown that early Pulmonary Rehabilitation has considerable short−term benefits in patients with COPD who have been recently discharged following a hospital admission for worsening of their symptoms . We hypothesise that these benefits are long−lasting, and may reduce use of healthcare resources and costs to the NHS.
1. Spruit, M.A., et al., Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF−I. Thorax, 2003. 58(9): p. 752−6.
2. Seemungal, T.A., et al., Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1998. 157(5 Pt 1): p. 1418−22.
3. Man, W.D., et al., Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ, 2004. 329(7476): p. 1209.
Description of Study:
Based on the results of our pilot study , we hypothesise that early pulmonary rehabilitation (EPR) leads to long term improvements in exercise capacity, quality of life, use & resulting costs of healthcare resources, peripheral muscle strength and daily activity levels. The null hypothesis is that EPR does not lead to a significant difference in outcome when compared to usual care (UC).
EXPERIMENTAL DESIGN AND METHODS: This is a prospective randomised controlled clinical trial of EPR vs. usual care.By using a control group, statistically significant differences in outcome can be attributed to EPR. No treatment considered to be part of routine care is being withheld from the UC group.
Patients: Patients studied will be those with an acute exacerbation of COPD deemed sufficiently unwell by the duty medical registrar to warrant hospital admission. Exclusion criteria will include significant co−morbidity that could limit exercise training, and attendance at a pulmonary rehabilitation programme in the preceding year. In−patient treatment will include standard therapy (nebulised bronchodilators, oxygen, non−invasive ventilation (if required), antibiotics and a 1−2 week course of oral prednisolone 30−40mg daily). On hospital discharge, patients will be allocated either to the early pulmonary rehabilitation (EPR) group (within 7 days of hospital discharge) or usual care (UC) i.e. routine outpatient and primary−care follow−up.
PROTOCOL: In the 48 hours before planned hospital discharge, the following measurements will be made in all patients:
1. Pulmonary function tests, including ear−lobe blood gases, spirometry, lung volumes, and transfer factor.
2. Anthropometric data, including height, weight, body mass index, lean body mass (as measured by bio−electrical impedance)
3. Field exercise capacity as measured by the incremental shuttle walk, a standard externally paced, incremental, maximal,corridor−walking test .
4. Disease−specific and generic health status, as measured by the Chronic Respiratory Diseases Questionnaire (CRDQ) ,St George's Respiratory Questionnaire (SGRQ) . Interviews will take place in the lung function department at King's College Hospital.
5. Cardiopulmonary exercise testing in a subset of voulnteers, with measurements of VO2, and VCO2 and lactic acid.
6. Non−volitional and volitional quadriceps strength: twitch quadriceps tension following supramaximal stimulation of femoral nerve and maximum isometric voluntary contraction. This is a painless supramaximal method of assessing quadriceps strength and fatigue  .
7. Endurance walking capacity (endurance shuttle walk)
8. Health resource usage (see later). The EuroQol (EQ−5D) instrument  will be used as the main measure of health−related quality−of−life in the economic evaluation.
The measurements made at baseline will be repeated at 3 and 12 months. Of note, as this study is a prospective longitudinal study, patients will be familiarised with the exercise tests in the days before discharge to minimise learning effect. Verbal encouragement during exercise testing will be standardised to avoid researcher effects. The assessor will be blinded to the subject's intervention. However owing to the nature of the intervention, it will not be possible to blind the subjects to their intervention.
RANDOMISATION: At discharge, patients will be allocated to either a hospital outpatient exercise rehabilitation programme, or usual care. Due to the numbers to be studied, allocation of treatments using the minimisation method will be used to ensure comparable groups. The following factors will be taken into account:
1. Age (above and below 70)
2. Gender (male/female)
3. Hospital Discharge incremental shuttle walk distance (more or less than 100 metres).
4. Length of Hospital Admission (more or less than 7 days)
5. FEV1 more or less than 30% predicted
INTERVENTION: Patients allocated to the EPR group will attend a pulmonary rehabilitation programme within 7 days of hospital discharge. This will consist of two sessions a week for 8 weeks, and will be supervised by a multi−disciplinary team consisting of physiotherapists, occupational therapists, nurses and dieticians as well as the clinical research fellow funded by the proposed grant. Each session consists of 60 minutes exercise, made up of aerobic walking and cycling exercise plus lower and upper limb strength and endurance exercise, and 1 hour of discussion focusing on psychosocial and lifestyle issues, with a particular emphasis on nutrition and domestic activity. The EPR group will be also be given an individualised home exercise programme, encouraging daily exercise. The UC group will receive usual outpatient and primary care follow−up.
HEALTH ECONOMICS: The EuroQol (EQ−5D) instrument will be used as the main measure of health−related quality−of−life in the economic evaluation . It has been developed by a collaborative group of European researchers as a preference−based index, suitable for the calculation of QALYs. The EQ−5D is one of two instruments currently recommended for use in economic evaluations . Information on patients' use of health services will be collected by a review of hospital notes, patient recall and a home diary issued to all study participants. The resources included will be: hospital admissions, inpatient days, ITU days, outpatient consultations, A&E attendances, and primary care surgery and home visits.
SAMPLE SIZE: Our preliminary pilot study was powered to detect a 50−metre difference in incremental shuttle walk at the 5% significance level with 90% power. Based on the health resource usage data collected from this pilot study, to detect a 50% reduction in hospital readmission rate at the 5% significance level with 80% power would require a minimum of 60 patients (30 in each group). We propose to study 80 patients in this study
1. Man, W.D., et al., Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ, 2004. 329(7476): p. 1209.
2. Singh, S.J., et al., Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax, 1992. 47(12): p. 1019−24.
3. Guyatt, G.H., et al., A measure of quality of life for clinical trials in chronic lung disease. Thorax, 1987. 42(10): p. 773−8.
4. Jones, P.W., et al., A self−complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis, 1992. 145(6): p. 1321−7.
5. Man, W.D., et al., Non−volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax, 2003. 58(8): p. 665−9.
6. Polkey, M.I., et al., Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve, 1996. 19(5): p. 549−55.
7. Brooks, R., EuroQol: the current state of play. Health Policy, 1996. 37(1): p. 53−72.
8. Brazier, J., M. Deverill, and C. Green, A review of the use of health status measures in economic evaluation. J Health Serv Res Policy, 1999. 4(3): p. 174−84.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Early pulmonary rehabilitation (EPR)
Basildon University Hospital
King's College Hospital NHS Trust
Published on BioPortfolio: 2014-07-24T14:19:53-0400
This is a study to evaluate the effects of early pulmonary rehabilitation within 10 days after discharge from the hospital after a COPD exacerbation on exercise tolerance, exacerbations, r...
Our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of c...
The primary aim of this clinical study is to investigate if pulmonary rehabilitation can increase exercise capacity and quality of life in dyspneic mild chronic obstructive pulmonary disea...
While pulmonary rehabilitation provides benefits to people with COPD, only 1.5% have access to pulmonary rehabilitation each year. The main barriers are related to travel and transportatio...
COPD is characterised by irreversible airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response. This inflammation can be amplified with ...
Purpose of this study was to analyze the impact of a pulmonary rehabilitation (PR) program on the measured inspiratory capacity (IC) in patients with chronic obstructive pulmonary disease (COPD) while...
1.2 million people in the UK have chronic obstructive pulmonary disease (COPD) that causes breathlessness, difficulty with daily activities, infections and hospitalisation. Pulmonary rehabilitation ...
Some patients with chronic obstructive pulmonary disease (COPD) fail to achieve health benefits with pulmonary rehabilitation (PR). Exercise intensity and load represent stimulus for adaptation but it...
Despite pulmonary rehabilitation (PR) being an evidence-based treatment recommended for people with chronic obstructive pulmonary disease (COPD), referral to PR seems to be low. Collating the evidence...
COPD patients experience a sustained deterioration of several capacities. Those with severe COPD undergo a considerable decline in their physical and functional capacities, but pulmonary rehabilitatio...
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
The diagnosis and treatment of human responses of individuals and groups to actual or potential health problems with the characteristics of altered functional ability and altered life-style. (American Nurses Association & Association of Rehabilitation Nurses. Standards of Rehabilitation Nursing Practice, 1986, p.2)
Studies and research concerning the psychological, educational, social, vocational, industrial, and economic aspects of REHABILITATION.
Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.
A rehabilitation therapy for removal of copious mucus secretion from the lung of patients with diseases such as CHRONIC BRONCHITIS; BRONCHIECTASIS; PULMONARY ABSCESS; or CYSTIC FIBROSIS. The patient's head is placed in a downward incline (so the TRACHEA is inferior to the affected area) for 15- to 20-minute sessions.
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza, Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...
COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all lead to the airways in the lungs becoming damaged and thus narrower, making inhalation and exhalation harder...
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal. When you come into contact with something that irritates your...